Chief Scientific Officer and Head, Research and Early Development (retired) @ Cytomx Therapeutics Inc (January 2015 - December 2020)
Associate Clinical Professor of Medicine (retired) @ (January 1990 - January 2020)
Chief Scientific Officer, SVP and Head of Research @ Five Prime Therapeutics, Inc. (March 2012 - December 2014)
Senior VP, Head of R and D @ (February 2009 - March 2012)
Vice President, Research @ (April 2006 - December 2008)
VP, Research @ Chiron Corporation (January 2003 - January 2006)
Michael Kavanaugh Education
Vanderbilt University
M.D. (Medicine)
1979-1983
Yale University
Bachelor's degree (Molecular Biochemistry and Biophysics)
1974-1978
Michael Kavanaugh Skills
R&D
Drug Discovery
Biotechnology
Drug Development
Clinical Development
Protein Chemistry
Protein Engineering
Biochemistry
Molecular Biology
Medicine
Oncology
Cardiovascular Disease
Immunology
Infectious Diseases
Research
Translational Medicine
Clinical Trials
Clinical Research
Sales
Technology Transfer
Development
Cancer
Data Analysis
Lifesciences
Strategic Planning
Science
Pharmaceutical Industry
SAN
Strategy
Healthcare Management
Business Strategy
Management
Project Management
Michael Kavanaugh Summary
Michael Kavanaugh, based in Orinda, CA, US, is currently a Independent Director at AmMax Bio., Inc.. Michael Kavanaugh brings experience from previous roles at Inversion Therapeutics, Inc., EpiBiologics, Inc., CytomX Therapeutics; Eureka; Nitrase; Acelot, others not disclosed and Kavanaugh Consulting Services LLC. Michael Kavanaugh holds a 1979 - 1983 M.D. in Medicine @ Vanderbilt University. With a robust skill set that includes R&D, Drug Discovery, Biotechnology, Drug Development, Clinical Development and more. Michael Kavanaugh has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Kavanaugh?
Find contact details for 700 million professionals.